180 related articles for article (PubMed ID: 26164788)
1. The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice.
Bacci S; Laurino A; Manni ME; Landucci E; Musilli C; De Siena G; Mocali A; Raimondi L
Eur J Pharmacol; 2015 Oct; 764():346-352. PubMed ID: 26164788
[TBL] [Abstract][Full Text] [Related]
2. The role of mast cells in cellular modifications evoked by Exendin-4 in treated wounds: a preclinical study.
Paroli G; Murciano N; Mancini C; Soldaini M; Rijli S; DeSiena G; Bacci S
J Wound Care; 2022 Aug; 31(8):701-708. PubMed ID: 36001707
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing.
Seo E; Lim JS; Jun JB; Choi W; Hong IS; Jun HS
J Transl Med; 2017 Feb; 15(1):35. PubMed ID: 28202074
[TBL] [Abstract][Full Text] [Related]
4. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice.
Yin QH; Zhang R; Li L; Wang YT; Liu JP; Zhang J; Bai L; Cheng JQ; Fu P; Liu F
J Biol Chem; 2016 Dec; 291(51):26487-26501. PubMed ID: 27784780
[TBL] [Abstract][Full Text] [Related]
6. Pien Tze Huang accelerated wound healing by inhibition of abnormal fibroblast apoptosis in Streptozotocin induced diabetic mice.
Yan Y; Liu X; Zhuang Y; Zhai Y; Yang X; Yang Y; Wang S; Hong F; Chen J
J Ethnopharmacol; 2020 Oct; 261():113203. PubMed ID: 32721552
[TBL] [Abstract][Full Text] [Related]
7. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
Yang G; Lei Y; Inoue A; Piao L; Hu L; Jiang H; Sasaki T; Wu H; Xu W; Yu C; Zhao G; Ogasawara S; Okumura K; Kuzuya M; Cheng XW
Atherosclerosis; 2017 Sep; 264():1-10. PubMed ID: 28734203
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and pro-healing impacts of exendin-4 treatment in Zucker diabetic rats: Effects on skin wound fibroblasts.
Wolak M; Staszewska T; Juszczak M; Gałdyszyńska M; Bojanowska E
Eur J Pharmacol; 2019 Jan; 842():262-269. PubMed ID: 30391742
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory switch from Gαs to Gαi signaling by Glucagon-like peptide-1 receptor in murine splenic monocyte following burn injury.
Zhang QH; Hao JW; Li GL; Ji XJ; Yao XD; Dong N; Yao YM
Inflamm Res; 2018 Feb; 67(2):157-168. PubMed ID: 29022064
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes.
Góralska J; Śliwa A; Gruca A; Raźny U; Chojnacka M; Polus A; Solnica B; Malczewska-Malec M
Acta Biochim Pol; 2017; 64(3):423-429. PubMed ID: 28822994
[TBL] [Abstract][Full Text] [Related]
11. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
12. Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation.
Garczorz W; Gallego-Colon E; Kosowska A; Kłych-Ratuszny A; Woźniak M; Marcol W; Niesner KJ; Francuz T
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29283509
[TBL] [Abstract][Full Text] [Related]
13. Indirect effects of glucagon-like peptide-1 receptor agonist exendin-4 on the peripheral circadian clocks in mice.
Ando H; Ushijima K; Fujimura A
PLoS One; 2013; 8(11):e81119. PubMed ID: 24260546
[TBL] [Abstract][Full Text] [Related]
14. Effect of herbal mixture composed of Alchemilla vulgaris and Mimosa on wound healing process.
Choi J; Park YG; Yun MS; Seol JW
Biomed Pharmacother; 2018 Oct; 106():326-332. PubMed ID: 29966977
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation.
Iwaya C; Nomiyama T; Komatsu S; Kawanami T; Tsutsumi Y; Hamaguchi Y; Horikawa T; Yoshinaga Y; Yamashita S; Tanaka T; Terawaki Y; Tanabe M; Nabeshima K; Iwasaki A; Yanase T
Endocrinology; 2017 Dec; 158(12):4218-4232. PubMed ID: 29045658
[TBL] [Abstract][Full Text] [Related]
16. Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway.
Gallego-Colon E; Klych-Ratuszny A; Kosowska A; Garczorz W; Aghdam MRF; Wozniak M; Francuz T
Pharmacol Rep; 2018 Feb; 70(1):178-183. PubMed ID: 29414148
[TBL] [Abstract][Full Text] [Related]
17. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.
Nie ZJ; Zhang YG; Chang YH; Li QY; Zhang YL
Biomed Pharmacother; 2018 Oct; 106():1364-1369. PubMed ID: 30119208
[TBL] [Abstract][Full Text] [Related]
19. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
Kolligs F; Fehmann HC; Göke R; Göke B
Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
[TBL] [Abstract][Full Text] [Related]
20. Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus.
Owji AA; Khoshdel Z; Sanea F; Panjehshahin MR; Shojaee Fard M; Smith DM; Coppock HA; Ghatei MA; Bloom SR
Brain Res; 2002 Mar; 929(1):70-5. PubMed ID: 11852032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
